渲染靶标:SSR
Render Timestamp: 2025-03-23T22:54:34.435Z
Commit: 779953b12a5930618aae6aca7c87fb286faeb1d7
XML generation date: 2025-03-07 13:08:10.454
Product last modified at: 2025-01-01T09:06:36.647Z
1% for the Planet 标识
PDP - Template Name: Polyclonal Antibody
PDP - Template ID: *******59c6464

TCF4 Antibody #2566

We recommend the following alternatives

Filter:
  • WB
  • IP
  • ChIP
Western Blotting Image 1: TCF4 Antibody
Western blot analysis of whole cell lysates from DLD1 and HCT116 cells, using TCF4 antibody.
This product is discontinued

Inquiry Info. # 2566

Please see our recommended alternatives.

Supporting Data

REACTIVITY H
SENSITIVITY Endogenous
MW (kDa) 58, 79
SOURCE Rabbit
Application Key:
  • WB-Western Blotting 
  • IP-Immunoprecipitation 
  • ChIP-Chromatin Immunoprecipitation 
Species Cross-Reactivity Key:
  • H-Human 

Product Information

Product Usage Information

Application Dilution
Western Blotting 1:1000
Immunoprecipitation 1:50
Chromatin IP 1:25

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Protocol

Specificity / Sensitivity

TCF4 Antibody detects endogenous levels of total TCF4 protein. It is expected to recognize most, if not all, human TCF4 splicing isoforms.

Species Reactivity:

Human

The antigen sequence used to produce this antibody shares 100% sequence homology with the species listed here, but reactivity has not been tested or confirmed to work by CST. Use of this product with these species is not covered under our Product Performance Guarantee.

Species predicted to react based on 100% sequence homology:

Mouse, Chicken

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu330 of human TCF4. Antibodies are purified by protein A and peptide affinity chromatography.

Background

LEF1 and TCF are members of the high mobility group (HMG) DNA-binding protein family of transcription factors that consists of the following: Lymphoid Enhancer Factor 1 (LEF1), T Cell Factor 1 (TCF1/TCF7), TCF3/TCF7L1, and TCF4/TCF7L2 (1). LEF1 and TCF1/TCF7 were originally identified as important factors that regulate early lymphoid development (2) and act downstream in Wnt signaling. LEF1 and TCF bind to Wnt response elements to provide docking sites for β-catenin, which translocates to the nucleus to promote the transcription of target genes upon activation of Wnt signaling (3). LEF1 and TCF are dynamically expressed during development and aberrant activation of the Wnt signaling pathway is involved in many types of cancers, including colon cancer (4,5).

TCF4, also known as TCF7L2, is expressed widely during development. Gene targeting study indicates that it is required to maintain the crypt stem cells of the small intestine (5, 6). TCF4 has many different splicing isoforms and they are expressed differentially in tissues and in cancers of different stages (8, 9). Studies also indicate that variant of the TCF4 gene confers an increased risk of type 2 diabetes (10).
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our Trademark Information page.